← Evidence map

ArticleJAMA oncology2019

Anlotinib for Refractory Advanced Non-Small Cell Lung Cancer in China.

Xin-Zu ChenPubMed ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30489609